Correlation Between Electromed and Tela Bio
Can any of the company-specific risk be diversified away by investing in both Electromed and Tela Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Electromed and Tela Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Electromed and Tela Bio, you can compare the effects of market volatilities on Electromed and Tela Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Electromed with a short position of Tela Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Electromed and Tela Bio.
Diversification Opportunities for Electromed and Tela Bio
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Electromed and Tela is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Electromed and Tela Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tela Bio and Electromed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Electromed are associated (or correlated) with Tela Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tela Bio has no effect on the direction of Electromed i.e., Electromed and Tela Bio go up and down completely randomly.
Pair Corralation between Electromed and Tela Bio
Given the investment horizon of 90 days Electromed is expected to generate 0.74 times more return on investment than Tela Bio. However, Electromed is 1.35 times less risky than Tela Bio. It trades about 0.21 of its potential returns per unit of risk. Tela Bio is currently generating about -0.1 per unit of risk. If you would invest 1,497 in Electromed on September 2, 2024 and sell it today you would earn a total of 1,581 from holding Electromed or generate 105.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Electromed vs. Tela Bio
Performance |
| Timeline |
| Electromed |
| Tela Bio |
Electromed and Tela Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Electromed and Tela Bio
The main advantage of trading using opposite Electromed and Tela Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Electromed position performs unexpectedly, Tela Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tela Bio will offset losses from the drop in Tela Bio's long position.| Electromed vs. Profound Medical Corp | Electromed vs. Si Bone | Electromed vs. Nevro Corp | Electromed vs. Orthopediatrics Corp |
| Tela Bio vs. Profound Medical Corp | Tela Bio vs. Si Bone | Tela Bio vs. Nevro Corp | Tela Bio vs. Orthopediatrics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |